LexOrbis
Facebook Twitter LinkedIn

Menu

  • Home
  • About Us
    • Who we are
    • Our People
    • Our Reach
  • Practice
    • Patents
    • Designs
    • Trademarks
    • Copyright
  • Global IP Solutions
    • Patent Search & Analytics
      • Knock-out Search
      • Patentability Search
      • Freedom to Operate
      • Invalidity Search
      • Infringement Search
      • Competitor Watch
      • Landscape / White Space Analysis
    • Patent Drafting
    • Global Patent Filing & Prosecution
      • Pre-Filing Review
      • Patent Drawings
      • Application Preparation and E-filing
      • Office Action Response
      • IDS Management
      • Post Allowance Review
      • Patent Proofreading
      • PTA Calculation
      • Paralegal Support
    • Trademark Search & Watch
      • Trademark Comprehensive Search
      • Trademark Watch
      • Counterfeit Watch
      • Domain Name Watch
    • Global Trademark Filing & Prosecution
      • Pre-Filing Review
      • Application Preparation and E-filing
      • Examination Report Response
      • Paralegal Support
    • IP Portfolio Management
      • IP Docketing
      • Data Validation
      • Invoice Management and Spend Analysis
      • IP Recordals
      • Patent Annuities
      • Trademark Renewals and Restoration
      • Special Projects
  • Updates
  • Events
  • Recognitions
  • Careers
  • Contact

Patent

Complying with first filing or foreign filing permission requirement in India amid COVID19 pandemic

April 24, 2020 LexOrbis Patent

India is currently under lockdown due to the ongoing pandemic of the novel coronavirus, also known as COVID-19. All government offices including the […]

Can the National Government Infringe a Patent

April 17, 2020April 17, 2020 LexOrbis Patent

The national governments grant the patents rights. Does it mean that government is immune to the reach of the patent right particularly infringement? […]

Rejecting Pre-Grant Opposition, IPO Grants Patent to Gilead’s HIV Drug Cobicistat

April 17, 2020April 17, 2020 LexOrbis Patent

The India Patent Office on February 24, 2020 granted a patent to Cobicistat, a drug for use in HIV and AIDS, of a […]

Complementary advances can be research or imitation

April 16, 2020April 16, 2020 LexOrbis Patent

In replying to a compliment Isaac Newton wrote, “If I have seen further, it is by standing on the shoulders of giants.” He […]

Compensating delay in granting of patents

April 16, 2020 LexOrbis Patent

Over recent years, the Office of the Controller General of Patents, Designs and Trademarks (Indian Patent Office or IPO) has significantly reduced the […]

Additional disclosure requirements for biotech inventions in India

April 8, 2020 LexOrbis Patent

Seemingly, inventions relating to biotechnology are magnetically more attracted to non-patentable clauses of Section 3 of Indian Patent Act. Therefore, when filing patent applications relating to biotechnology, […]

Public Non-Commercial Use: Compulsory Licence on Patents During Pandemic

April 1, 2020 LexOrbis Patent

In the corona virus induced impeding crisis, it is believed that owners of the patents on test kits and other medicinal requirements would […]

Natural calamity and patent office time lines

March 25, 2020 LexOrbis Patent

Certain offices such as patent office universally requires that the processes involved in the process or proceeding related to the patent applications are […]

Recourse measures for apprehension of infringement

March 24, 2020 LexOrbis Patent

Threats of infringement weigh heavily on patentees who therefore closely monitor active and passive unauthorized uses of their patented inventions. This is not […]

FFL requirement for newly added subject matter

March 24, 2020 LexOrbis Patent

One of the peculiar provisions of Indian patent law is that an invention involving a resident inventor shall not be revealed outside India […]

Post navigation

← Older posts
Newer posts →

News & Updates

  • News (115)
  • Copyright (131)
  • Patent (515)
  • Trademark (486)
  • Others (653)
    • Events (69)
  • Recognitions (126)
  • Designs (4)

Recent Posts

  • Refusal of Pharmaceutical Combination Patent Application Set Aside by Delhi High Court August 18, 2026
  • Pet Appetite and Weight-Loss Drug Survives Patent Rejection: Madras High Court Finds Refusal Order Arbitrary August 18, 2026
  • Analysing the MSME Development (Amendment) Bill, 2026: Proposed Changes to Registration, Delayed Payments and Dispute Resolution August 18, 2026
  • Gujarat High Court Sets Aside Interim Injunction Due to Erred Assessment of Evidence August 18, 2026
  • CDSCO Issues Guidance on Medical Device Software under the Medical Devices Rules, 2017 August 13, 2026

Archives

Subscribe

Name

Email


© 2026 - Lexorbis. All Rights Reserved.   Privacy Policy  |  Terms of Use

This website follows the relevant rules of the Bar Council of India. By clicking, “I Agree” below, the user acknowledges and confirms that the contents of website are meant to provide necessary information about the firm, LexOrbis and updates on relevant laws in India. The information provided herein is not legal advice, and the Firm disclaims all liability arising from reliance placed by the user on the information contained therein. The Firm has made all efforts to ensure the accuracy of the contents of this website. The user also confirms that there has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from the Firm or any of its members to solicit any work or advertise through this website.

Please read and accept this Website’s Terms of Use and Privacy Policy before accessing the same.

I Agree I Disagree